Skip to main content
Caplight Logo









Myze

Myze

Private
United StatesConsumer & Commercehttps://helpmyze.com/

Last Round

Accelerator

Dec 15, 2021

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Myze operates in Consumer & Commerce and is based in the United States. Its latest recorded funding round was an Accelerator round in December 2021.

Myze is a healthcare technology company that operates an eye care products platform intended for daily eye hygiene and dry eye management, offering preservative-free products, educational resources, and expert guidance.

Sector

Consumer & Commerce

Verticals

D2C Brands, Subscription Commerce, E-commerce, Home & Lifestyle, Fashion & Beauty

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Myze Comparables

Compare Myze with similar companies based on industry and business-model similarity.

Myze comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CorneaCare
93%
Peeq Pro
74%
Alcon
61%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Myze Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 15, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Myze Investors

Notable investors and investment history

Myze investors
InvestorRounds
Westchester AngelsAccelerator
Element 46 Tech AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 65% MoM, from 4.7K to 7.8K.

  • Jan 23, 2026

    Monthly visitors increased 88% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Myze Filings

Explore SEC and related filing metadata, where available.

Myze filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Myze's valuation, stock price, and market status.

Is Myze a public or private company?

Myze is a private company.

What is the current stock price of Myze?

Myze is a private company, so its shares have no public market price. Caplight tracks Myze's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Myze worth (valuation)?

Valuation information for Myze is not publicly available.

Can I buy Myze stock?

Myze shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Myze's last funding round?

Myze's most recent funding round was Accelerator on December 15, 2021.

Who are the main investors in Myze?

Key investors in Myze include Westchester Angels, Element 46 Tech Accelerator.

Will Myze IPO soon?

No public IPO plans have been announced for Myze.

How can I track Myze secondary market activity?

Caplight tracks bids, offers, and trades in Myze's shares on secondary markets.

Firmographic Details

HeadquartersUnited States
Employee Range1
Year Founded2021
Last FundingDec 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?